太阳成集团tyc234cc(官方VIP下载)-Best App Store

2014-Efficacy and safety of house dust mite sublingual immunotherapy in monosensitized and polysensitized children with respiratory allergic diseases. (Int Forum Allergy Rhinol, IF=2.521)

2014-Efficacy and safety of sublingual immunotherapy in children aged 3–13 years with allergic rhinitis. (Am J Rhinol Allergy, IF=2.015)

2016-Increased Expression of miR-146a in Children With Allergic. (Allergy Asthma Immunol Res, IF=5.026)

2016-The effects of house dust mite sublingual immunotherapy in patients according to duration. (Int Forum Allergy Rhinol, IF=2.521)

2017-Clinical evaluation for sublingual immunotherapy with Dermatophagoides farinae drops in adult patients with allergic asthma. (Ir J Med Sci, IF=1.031)

2017-Nonadherence to sublingual immunotherapy in allergic rhinitis a real-life analysis. (Int Forum Allergy Rhinol, IF=2.521)

2017-The efficacy and safety of sublingual immunotherapy in children and adult patients with allergic rhinitis. (Allergol Immunopathol, IF=1.64)

2018-Efficacy and safety of sublingual immunotherapy with Dermatophagoides farinae drops in pre-school and school age children with allergic rhinitis. (Allergol Immunopathol, IF=1.64)

2019-Long-Term Efficacy of Sublingual Mite Immunotherapy in Monosensitized and Polysensitized Children with Allergic Rhinitis: A 7-Year Prospective Study. (Int Arch Allergy Immunol, IF= 2.932)

2014-Efficacy and safety of sublingual immunotherapy in children aged 3–13 years with allergic rhinitis